reports
- GlobalData Healthcare Department
Mast Therapeutics Inc (MSTX) - Pharmaceuticals & Healthcare - Deals an...
Summary Mast Therapeutics Inc (Mast Therapeutics) is a biopharmaceutical company, which develops clinical-stage therapies for serious or life-threatening diseases. The company develops therapies for sickle cell disease, a chronic, genetic disorder for rare or orphan disease. The company’s lead product MST-188 (also known as vepoloxamer) is being developed for the treatment of of vaso-occlusive crisis in patients with sickle cell disease. Its pipeline includes development programs in the areas...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.